SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
What is the latest Consolidated Net Profit of SHREE GANESH REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹1,047,056 Cr |
| Mar2020 | ₹6.24 Cr |
| Mar2019 | ₹6.24 Cr |
How is Consolidated Net Profit of SHREE GANESH REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | -100.00 | |
| Mar2024 | ₹1,047,056 Cr | 16,793,096.95 | |
| Mar2020 | ₹6.24 Cr | 0.00 | |
| Mar2019 | ₹6.24 Cr | - | |
Compare Consolidated Net Profit of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹829.8 Cr | 7.8% | 24.5% | 6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 7.8% |
24.5% |
6.9% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses